article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119
article thumbnail

Unveiling the Green: Demystifying Cannabis and Its Multifaceted Benefits

The Herb Collective

This versatile plant, which has been both vilified and celebrated throughout history, is finally getting the recognition it deserves in various sectors, including medicine, wellness, and sustainable development. Cannabidiol (CBD), one of the many compounds found in cannabis, has been at the forefront of this revolution.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

It’s Underage Drinking That Impairs Brain Development, Not Cannabis Use

SpeedWeed

Some of these claims were based on outdated research, but scientists are now discovering that alcohol , not weed, is responsible for these developmental issues. A new study published in the Biological Psychiatry journal is adding to the growing evidence that alcohol impairs adolescent brain development in ways that weed does not.

article thumbnail

Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application

Cannabis Law Report

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

article thumbnail

Press Release: MindMed Engages in Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System

Cannabis Law Report

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

article thumbnail

New Study Finds Smoking Weed Has Less COPD Risks Than Tobacco

Veriheal

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

article thumbnail

City Lights Bookshop & Synergetic Press Present Free 2 Day Event celebrating the pioneering legacy of Sasha and Ann Shulgin for the launch of the first Shulgin book since 2011, The Nature of Drugs: History, Pharmacology, and Social Impact. 

Cannabis Law Report

Session 1: The Shulgin’s Pioneering Psychedelic Research (12:00 PM-2:00 PM PDT). Moderator: Bob Jesse – researcher, engineer, convener of the Council on Spiritual Practices. Paul Daley – Chief Science Officer and Chemist, Alexander Shulgin Research Institute. Allan Badiner – editor of Zig Zag Zen: Buddhism and Psychedelics.

Events 83